NCT01691560View on ClinicalTrials.gov

Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Dentine Hypersensitivity
Interventions
DRUG

5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice

Dentifrice containing 5.0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate

DRUG

0% calcium sodium phosphosilicate/sodium monofluorophosphate dentifrice

Dentifrice containing 0% w/w calcium sodium phosphosilicate and 1500ppmF as sodium monofluorophosphate

DRUG

Sodium monofluorophosphate dentifrice

Dentifrice containing 1000 ppmF as sodium monofluorophosphate

DRUG

Sodium fluoride dentifrice

Dentifrice containing 1100 ppmF as sodium fluoride

Trial Locations (1)

89121-5466

BioSci Research America, Las Vegas

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators (1)

BioSci Research
All Listed Sponsors
collaborator

BioSci Research

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY

NCT01691560 - Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity | Biotech Hunter | Biotech Hunter